HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janne-Merete Torset Øien Selected Research

MOC31PE immunotoxin

1/2021ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis.
7/2017Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janne-Merete Torset Øien Research Topics

Disease

2Neoplasm Metastasis (Metastasis)
01/2021 - 07/2017
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 07/2017
1Neoplasms (Cancer)
07/2017

Drug/Important Bio-Agent (IBA)

2MOC31PE immunotoxinIBA
01/2021 - 07/2017
1Epithelial Cell Adhesion MoleculeIBA
07/2017

Therapy/Procedure

1Cytoreduction Surgical Procedures
07/2017
1Hyperthermic Intraperitoneal Chemotherapy
07/2017